Baird Financial Group Inc. grew its stake in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 13.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 339,598 shares of the health services provider's stock after acquiring an additional 38,955 shares during the quarter. Baird Financial Group Inc. owned 0.26% of Select Medical worth $5,671,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Price T Rowe Associates Inc. MD lifted its position in Select Medical by 1.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,755,298 shares of the health services provider's stock valued at $296,515,000 after acquiring an additional 270,488 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Select Medical by 4.7% in the first quarter. Vanguard Group Inc. now owns 13,316,069 shares of the health services provider's stock worth $222,378,000 after purchasing an additional 603,079 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Select Medical by 3.1% during the first quarter. Principal Financial Group Inc. now owns 2,476,816 shares of the health services provider's stock valued at $41,363,000 after purchasing an additional 73,308 shares in the last quarter. Northern Trust Corp boosted its position in shares of Select Medical by 12.9% during the fourth quarter. Northern Trust Corp now owns 1,352,046 shares of the health services provider's stock valued at $25,486,000 after buying an additional 153,992 shares during the last quarter. Finally, Bank of America Corp DE increased its holdings in Select Medical by 46.7% in the 4th quarter. Bank of America Corp DE now owns 1,192,578 shares of the health services provider's stock worth $22,480,000 after buying an additional 379,598 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on SEM. Bank of America lowered their price target on Select Medical from $18.00 to $15.00 and set a "buy" rating on the stock in a report on Wednesday. UBS Group reissued a "neutral" rating and issued a $14.00 target price (down previously from $15.00) on shares of Select Medical in a report on Monday, August 4th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $19.20.
Check Out Our Latest Stock Report on Select Medical
Select Medical Stock Performance
Select Medical stock traded down $0.47 during trading on Wednesday, reaching $12.46. The company had a trading volume of 775,758 shares, compared to its average volume of 840,060. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of 11.75, a price-to-earnings-growth ratio of 0.53 and a beta of 1.25. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.92. The firm's 50-day simple moving average is $13.51 and its 200 day simple moving average is $15.21. Select Medical Holdings Corporation has a 52 week low of $11.65 and a 52 week high of $40.98.
Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.04. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The business had revenue of $1.34 billion during the quarter, compared to analysts' expectations of $1.35 billion. During the same quarter in the prior year, the business posted $0.60 earnings per share. The business's quarterly revenue was up 4.5% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Sell-side analysts forecast that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.
Select Medical Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th were paid a dividend of $0.0625 per share. The ex-dividend date was Wednesday, August 13th. This represents a $0.25 dividend on an annualized basis and a yield of 2.0%. Select Medical's dividend payout ratio (DPR) is presently 23.58%.
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.